Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2020
https://www.valueinhealthjournal.com/article/S1098-3015(17)32354-9/fulltext
Title :
Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32354-9&doi=10.1016/j.jval.2017.08.2020
First page :
A736
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1842